Monte Rosa Therapeutics
Arnaud Osmont is an experienced proteomics scientist currently employed at Monte Rosa Therapeutics since November 2020. Prior to this role, Arnaud worked as a scientist at Ridgeline Therapeutics for a brief period from June to October 2020. Arnaud's extensive background includes a long tenure at Novartis Institutes for BioMedical Research (NIBR), where Arnaud served as a scientist from April 2004 to May 2020. Arnaud holds a Master's degree in Analytical Chemistry from ECPM Ecole européenne de chimie polymères et matériaux de Strasbourg, completed between 2001 and 2004.
This person is not in any teams
This person is not in any offices
Monte Rosa Therapeutics
2 followers
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.